Andrew Haak, Ph.D.

Mayo Clinic
Catecholamine Signaling Regulates Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is an aggressive and fatal disease that causes scarring (fibrosis) of the lungs. Scarring causes stiffness in the lungs and makes it difficult to breathe. Lung damage from IPF is irreversible and progressive, meaning it gets worse over time. The processes that promote the chronic nature and prevent resolution of pulmonary fibrosis are not understood. We will investigate the role hormones called catecholamines (dopamine, norepinephrine and epinephrine) play in regulating pulmonary fibrosis. We will study how catecholamine cell signaling regulates the disease and test clinically approved drugs which regulate catecholamines in models of pulmonary fibrosis. The results could lead to a potential treatment that not only halts the progression of fibrosis but promotes its reversal and improves lung function.

Andrew Haak, Ph.D.
Freedom From Smoking Clinic Santori Aurora Public Library
Aurora, IL | Sep 01, 2020
Freedom From Smoking Clinic Waterford Place Cancer Resource Center
Aurora , IL | Sep 14, 2020